NO812642L - Anordning for administrering av medisinsk aktive substanser - Google Patents
Anordning for administrering av medisinsk aktive substanserInfo
- Publication number
- NO812642L NO812642L NO812642A NO812642A NO812642L NO 812642 L NO812642 L NO 812642L NO 812642 A NO812642 A NO 812642A NO 812642 A NO812642 A NO 812642A NO 812642 L NO812642 L NO 812642L
- Authority
- NO
- Norway
- Prior art keywords
- medically active
- active substance
- substance
- tissue
- stated
- Prior art date
Links
- 239000013543 active substance Substances 0.000 title claims description 28
- 239000000463 material Substances 0.000 claims description 22
- 239000000126 substance Substances 0.000 claims description 20
- 210000003101 oviduct Anatomy 0.000 claims description 17
- 210000001124 body fluid Anatomy 0.000 claims description 16
- 239000010839 body fluid Substances 0.000 claims description 16
- 238000003780 insertion Methods 0.000 claims description 11
- 230000037431 insertion Effects 0.000 claims description 11
- 230000008961 swelling Effects 0.000 claims description 11
- 210000003679 cervix uteri Anatomy 0.000 claims description 9
- 239000000178 monomer Substances 0.000 claims description 9
- 210000000056 organ Anatomy 0.000 claims description 9
- 241001465754 Metazoa Species 0.000 claims description 6
- 239000000017 hydrogel Substances 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 4
- 230000002209 hydrophobic effect Effects 0.000 claims description 4
- 150000003180 prostaglandins Chemical class 0.000 claims description 4
- 229920001577 copolymer Polymers 0.000 claims description 3
- 231100000433 cytotoxic Toxicity 0.000 claims description 3
- 230000001472 cytotoxic effect Effects 0.000 claims description 3
- 229940094443 oxytocics prostaglandins Drugs 0.000 claims description 3
- 231100000641 abortifacient agent Toxicity 0.000 claims description 2
- 230000000903 blocking effect Effects 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- 238000012546 transfer Methods 0.000 claims description 2
- 239000001096 (4-ethenyl-1-azabicyclo[2.2.2]octan-7-yl)-(6-methoxyquinolin-4-yl)methanol hydrochloride Substances 0.000 claims 1
- NNKXWRRDHYTHFP-HZQSTTLBSA-N (r)-[(2s,4s,5r)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol;hydron;dichloride Chemical compound Cl.Cl.C([C@H]([C@H](C1)C=C)C2)CN1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 NNKXWRRDHYTHFP-HZQSTTLBSA-N 0.000 claims 1
- 229960001811 quinine hydrochloride Drugs 0.000 claims 1
- 238000011282 treatment Methods 0.000 description 13
- 210000001519 tissue Anatomy 0.000 description 12
- 210000002808 connective tissue Anatomy 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000009772 tissue formation Effects 0.000 description 5
- 210000004291 uterus Anatomy 0.000 description 5
- 206010000210 abortion Diseases 0.000 description 4
- 231100000176 abortion Toxicity 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 210000004400 mucous membrane Anatomy 0.000 description 4
- 238000004873 anchoring Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 241000282412 Homo Species 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- 229960000901 mepacrine Drugs 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- GPKJTRJOBQGKQK-UHFFFAOYSA-N quinacrine Chemical compound C1=C(OC)C=C2C(NC(C)CCCN(CC)CC)=C(C=CC(Cl)=C3)C3=NC2=C1 GPKJTRJOBQGKQK-UHFFFAOYSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- QRIMLDXJAPZHJE-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(O)CO QRIMLDXJAPZHJE-UHFFFAOYSA-N 0.000 description 1
- KGIGUEBEKRSTEW-UHFFFAOYSA-N 2-vinylpyridine Chemical class C=CC1=CC=CC=N1 KGIGUEBEKRSTEW-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 208000031872 Body Remains Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical group CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical class C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 239000004015 abortifacient agent Substances 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical class [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052797 bismuth Chemical class 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical class [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940044683 chemotherapy drug Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- -1 diesters Chemical class 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Chemical compound CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 229910052751 metal Chemical class 0.000 description 1
- 239000002184 metal Chemical class 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- 125000005397 methacrylic acid ester group Chemical group 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000011458 pharmacological treatment Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000008174 sterile solution Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/42—Gynaecological or obstetrical instruments or methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
- A61F6/20—Vas deferens occluders; Fallopian occluders
- A61F6/22—Vas deferens occluders; Fallopian occluders implantable in tubes
- A61F6/225—Vas deferens occluders; Fallopian occluders implantable in tubes transcervical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Reproductive Health (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Surgery (AREA)
- Materials Engineering (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pregnancy & Childbirth (AREA)
- Medical Informatics (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Materials For Medical Uses (AREA)
- Surgical Instruments (AREA)
- Soil Working Implements (AREA)
- Medicines Containing Plant Substances (AREA)
- Finger-Pressure Massage (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE7910018A SE447446B (sv) | 1979-12-05 | 1979-12-05 | Anordning for tillforande av medicinskt aktiva substanser for att fremja en abort |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO812642L true NO812642L (no) | 1981-08-04 |
Family
ID=20339475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO812642A NO812642L (no) | 1979-12-05 | 1981-08-04 | Anordning for administrering av medisinsk aktive substanser |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0046761A1 (fr) |
| JP (1) | JPS57500362A (fr) |
| BR (1) | BR8009059A (fr) |
| DK (1) | DK313281A (fr) |
| NO (1) | NO812642L (fr) |
| SE (2) | SE447446B (fr) |
| WO (1) | WO1981001515A1 (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8103903L (sv) * | 1981-06-22 | 1982-12-23 | Medline Ab | Anordning for tillslutning av kroppskanaler |
| FR2522959A1 (fr) * | 1982-03-15 | 1983-09-16 | Hamou Jacques | Dispositif pour la contraception tubaire, reversible, par hysteroscopie |
| NZ200564A (en) * | 1982-05-10 | 1987-03-06 | Ahi Operations Ltd | Device for slowly releasing chemicals into body cavities of animals |
| FR2577797A1 (fr) * | 1985-02-22 | 1986-08-29 | Benardin Henri | Dispositif de contraception feminine |
| FR2582944B1 (fr) * | 1985-06-11 | 1990-10-26 | Commissariat Energie Atomique | Piece en polymere, notamment en polyurethane de polyoxyethylene a gonflement anisotrope, son procede de fabrication et son utilisation comme dilatateur du col uterin |
| AU3886893A (en) * | 1993-04-23 | 1994-11-21 | Bohdan Babinec | Method, device and apparatus for reversible contraceptive sterilization |
| ES2441341T3 (es) | 2001-05-29 | 2014-02-04 | Microvention, Inc. | Dispositivo de embolización vascular y procedimiento de fabricación del mismo |
| AU2005336143A1 (en) * | 2005-09-07 | 2007-03-15 | Gynaecologlq B.V. | Sealing stopper and assembly comprising such a sealing stopper |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3220960A (en) * | 1960-12-21 | 1965-11-30 | Wichterle Otto | Cross-linked hydrophilic polymers and articles made therefrom |
| FR1586811A (fr) * | 1966-01-06 | 1970-03-06 | ||
| US3674901A (en) * | 1966-07-26 | 1972-07-04 | Nat Patent Dev Corp | Surgical sutures |
| US3695921A (en) * | 1970-09-09 | 1972-10-03 | Nat Patent Dev Corp | Method of coating a catheter |
-
1979
- 1979-12-05 SE SE7910018A patent/SE447446B/sv not_active IP Right Cessation
-
1980
- 1980-12-04 BR BR8009059A patent/BR8009059A/pt unknown
- 1980-12-04 WO PCT/SE1980/000315 patent/WO1981001515A1/fr not_active Application Discontinuation
- 1980-12-04 EP EP81900021A patent/EP0046761A1/fr not_active Ceased
- 1980-12-04 JP JP56500174A patent/JPS57500362A/ja active Pending
-
1981
- 1981-07-14 DK DK313281A patent/DK313281A/da not_active Application Discontinuation
- 1981-08-04 NO NO812642A patent/NO812642L/no unknown
-
1982
- 1982-01-04 SE SE8200004A patent/SE8200004L/ not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| SE8200004L (sv) | 1982-01-04 |
| BR8009059A (pt) | 1982-04-06 |
| SE447446B (sv) | 1986-11-17 |
| SE7910018L (sv) | 1981-06-06 |
| JPS57500362A (fr) | 1982-03-04 |
| EP0046761A1 (fr) | 1982-03-10 |
| DK313281A (da) | 1981-07-14 |
| WO1981001515A1 (fr) | 1981-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4509504A (en) | Occlusion of body channels | |
| EP0035018B1 (fr) | Dispositif d'organes d'obturation de passages dans des corps vivants | |
| US9345867B2 (en) | Device implantable in tissue of a prostate gland or a bladder | |
| US3871374A (en) | Dispensing instrument | |
| DE69826371T2 (de) | Rohrförmige Sterilisationsvorrichtung für einen Eileiter | |
| US4579110A (en) | Tubular pessary as a contraceptive means | |
| US3822702A (en) | Dispensing method and apparatus | |
| US5269321A (en) | Retrievable pessary | |
| RU2008143224A (ru) | Имплантанты назолакримальной дренажной системы для медикаментозной терапии | |
| JP2002500644A (ja) | 子宮内化学的壊死化の方法、組成物、および装置 | |
| GB1569660A (en) | Occlusion of body channels | |
| NO812642L (no) | Anordning for administrering av medisinsk aktive substanser | |
| US3675648A (en) | Intrauterine contraceptive device | |
| US10010400B2 (en) | Devices and methods for local delivery of drug to upper urinary tract | |
| EP0556908B1 (fr) | Dispositif intrauterin et/ou intravaginal | |
| NO830596L (no) | Anordning for tillukning av kroppskanaler. | |
| AU2009215360A1 (en) | Recoverable intra-uterine system | |
| JPS6120304B2 (fr) | ||
| US3675647A (en) | Intrauterine contraceptive device | |
| KR830002835B1 (ko) | 개량된 체내도관 폐쇄장치 | |
| CA1122871A (fr) | Dispositif pour l'occlusion temporaire ou permanente de conduits de l'organisme | |
| Brundin | P-block as a contraceptive method | |
| FI71057B (fi) | Tillslutningskropp foer temporaer eller permanent tillslutningav aeggledarnas mynningpartier mot livmodern hos maennisk orch djur | |
| SK278481B6 (en) | The intrauterine contraceptive device with incidental elimination of menstrual pain | |
| Ragab et al. | Repeated Extra‐amniotic Administration of Prostaglandin F2α for Midtrimester Abortion |